Home › B-Cell Lymphoma › New York › New York City
B-Cell Lymphoma clinical trials in New York City, NY
18 studies for B-Cell Lymphoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RecruitingPhase 2
- Research Site, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RecruitingPhase 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- and 1 more
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecruitingPhase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RecruitingPhase 1/2
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecruitingPhase 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
RecruitingPhase 1/2
- Research Site, New York
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
RecruitingPhase 1/2
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
RecruitingPhase 1/2
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Recruiting
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recruiting
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
B-Cell Lymphoma trials in other cities
- Houston, TX16 studies
- Chicago, IL13 studies
- Nashville, TN11 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Cleveland, OH9 studies
- Boston, MA8 studies
- Salt Lake City, UT8 studies
- Washington, DC7 studies
- Pittsburgh, PA7 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.